The differentiation of bone marrow mesenchymal stem cells into chondrocyte-like cells on poly-l-lactic acid (PLLA) scaffolds

Biomaterials

Volumn 27, Issue 22, 2006, Pages 4069-4078

  Richardson, Stephen M ^a   Curran, Judith M ^b   Chen, Rui ^b   Vaughan Thomas, Anne ^b   Hunt, John A ^b   Freemont, Anthony J ^a   Hoyland, Judith Alison ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Confocal microscopy; Intervertebral disc; Mesenchymal stem cell; PCR; Polylactic acid; TGF

Indexed keywords

BIODEGRADATION; BONE; COLLAGEN; PATIENT TREATMENT; SCAFFOLDS; TISSUE CULTURE;

DISC DEGENERATION; INTERVERTEBRAL DISC (IVD); MESENCHYMAL STEM CELLS; TISSUE ENGINEERING;

CELLS;

POLYLACTIC ACID;

ADENOVIRUS; ARTICLE; BIODEGRADABILITY; BONE MARROW CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE REPLICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MESENCHYME CELL; NUCLEUS PULPOSUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TISSUE ENGINEERING;

ADENOVIRIDAE; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; HIGH MOBILITY GROUP PROTEINS; HUMANS; LACTIC ACID; MALE; MESENCHYMAL STEM CELLS; MICROSCOPY, CONFOCAL; MIDDLE AGED; POLYMERS; TISSUE ENGINEERING; TRANSCRIPTION FACTORS; TRANSFECTION;

ADENOVIRIDAE;

EID: 33646065056     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.03.017     Document Type: Article

References (51)

1. Masuoka K., Asazuma T., Ishihara M., Sato M., Hattori H., Ishihara M., et al. Tissue engineering of articular cartilage using an allograft of cultured chondrocytes in a membrane-sealed atelocollagen honeycomb-shaped scaffold (ACHMS scaffold). J Biomed Mater Res B Appl Biomater 75 1 (2005) 177-184
2. Chang C.H., Kuo T.F., Lin C.C., Chou C.H., Chen K.H., Lin F.H., et al. Tissue engineering-based cartilage repair with allogenous chondrocytes and gelatin-chondroitin-hyaluronan tri-copolymer scaffold: a porcine model assessed at 18, 24, and 36 weeks. Biomaterials 27 9 (2006) 1876-1888
3. Lisignoli G., Cristino S., Piacentini A., Toneguzzi S., Grassi F., Cavallo C., et al. Cellular and molecular events during chondrogenesis of human mesenchymal stromal cells grown in a three-dimensional hyaluronan based scaffold. Biomaterials 26 28 (2005) 5677-5686
4. Mauck R.L., Yuan X., and Tuan R.S. Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthritis Cartilage 14 2 (2006) 179-189
5. Xia W., Liu W., Cui L., Liu Y., Zhong W., Liu D., et al. Tissue engineering of cartilage with the use of chitosan-gelatin complex scaffolds. J Biomed Mater Res B Appl Biomater 71 2 (2004) 373-380
6. Ma H.L., Hung S.C., Lin S.Y., Chen Y.L., and Lo W.H. Chondrogenesis of human mesenchymal stem cells encapsulated in alginate beads. J Biomed Mater Res A 64 2 (2003) 273-281
7. Ishaug-Riley S.L., Okun L.E., Prado G., Applegate M.A., and Ratcliffe A. Human articular chondrocyte adhesion and proliferation on synthetic biodegradable polymer films. Biomaterials 20 23-24 (1999) 2245-2256
8. Rahman M.S., and Tsuchiya T. Enhancement of chondrogenic differentiation of human articular chondrocytes by biodegradable polymers. Tissue Eng 7 6 (2001) 781-790
9. Ma P.X., Schloo B., Mooney D., and Langer R. Development of biomechanical properties and morphogenesis of in vitro tissue engineered cartilage. J Biomed Mater Res 29 12 (1995) 1587-1595
10. Grande D.A., Halberstadt C., Naughton G., Schwartz R., and Manji R. Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. J Biomed Mater Res 34 2 (1997) 211-220
11. Li W.J., Danielson K.G., Alexander P.G., and Tuan R.S. Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. J Biomed Mater Res A 67 4 (2003) 1105-1114
12. Li W.J., Tuli R., Okafor C., Derfoul A., Danielson K.G., Hall D.J., et al. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 26 6 (2005) 599-609
13. Grad S., Kupcsik L., Gorna K., Gogolewski S., and Alini M. The use of biodegradable polyurethane scaffolds for cartilage tissue engineering: potential and limitations. Biomaterials 24 28 (2003) 5163-5171
14. Seguin C.A., Grynpas M.D., Pilliar R.M., Waldman S.D., and Kandel R.A. Tissue engineered nucleus pulposus tissue formed on a porous calcium polyphosphate substrate. Spine 29 12 (2004) 1299-1306
15. Wayne J.S., McDowell C.L., Shields K.J., and Tuan R.S. In vivo response of polylactic acid-alginate scaffolds and bone marrow-derived cells for cartilage tissue engineering. Tissue Eng 11 5-6 (2005) 953-963
16. Mizuno H., Roy A.K., Vacanti C.A., Kojima K., Ueda M., and Bonassar L.J. Tissue-engineered composites of anulus fibrosus and nucleus pulposus for intervertebral disc replacement. Spine 29 12 (2004) 1290-1297
17. El Amin S.F., Lu H.H., Khan Y., Burems J., Mitchell J., Tuan R.S., et al. Extracellular matrix production by human osteoblasts cultured on biodegradable polymers applicable for tissue engineering. Biomaterials 24 7 (2003) 1213-1221
18. Weir N.A., Buchanan F.J., Orr J.F., and Dickson G.R. Degradation of poly-l-lactide. Part 1: in vitro and in vivo physiological temperature degradation. Proc Inst Mech Eng [H] 218 5 (2004) 307-319
19. Humzah M.D., and Soames R.W. Human intervertebral disc: structure and function. Anat Rec 220 4 (1988) 337-356
20. Sive J.I., Baird P., Jeziorsk M., Watkins A., Hoyland J.A., and Freemont A.J. Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol 55 2 (2002) 91-97
21. Eyre D.R., and Muir H. Quantitative analysis of types I and II collagens in human intervertebral discs at various ages. Biochim Biophys Acta 492 1 (1977) 29-42
22. Freemont A.J., Peacock T.E., Goupille P., Hoyland J.A., O'Brien J., and Jayson M.I. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet 350 9072 (1997) 178-181
23. Freemont A.J., Jeziorska M., Hoyland J.A., Rooney P., and Kumar S. Mast cells in the pathogenesis of chronic back pain: a hypothesis. J Pathol 197 3 (2002) 281-285
24. Freemont A.J., Watkins A., Le Maitre C., Jeziorska M., and Hoyland J.A. Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy. J Pathol 196 4 (2002) 374-379
25. Macfarlane G.J., Thomas E., Croft P.R., Papageorgiou A.C., Jayson M.I., and Silman A.J. Predictors of early improvement in low back pain amongst consulters to general practice: the influence of pre-morbid and episode-related factors. Pain 80 1-2 (1999) 113-119
26. Maroudas A., Stockwell R.A., Nachemson A., and Urban J. Factors involved in the nutrition of the human lumbar intervertebral disc: cellularity and diffusion of glucose in vitro. J Anat 120 1 (1975) 113-130
27. Nomura T., Mochida J., Okuma M., Nishimura K., and Sakabe K. Nucleus pulposus allograft retards intervertebral disc degeneration. Clin Orthop 389 (2001) 94-101
28. Pearce R.H., Grimmer B.J., and Adams M.E. Degeneration and the chemical composition of the human lumbar intervertebral disc. J Orthop Res 5 2 (1987) 198-205
29. Hundal K., Watkins A., Le Maitre C.L., Freemont A.J., and Hoyland J.A. Chondrocyte senescence in intervertebral disc degeneration. J Pathol 198 Suppl. S (2002) 51A
30. Le Maitre C.L., Freemont A.J., and Hoyland J.A. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol 204 1 (2004) 47-54
31. Le Maitre C.L., Freemont A.J., and Hoyland J.A. The role of interleukin-1 in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther 7 (2005) R732-R745
32. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 5411 (1999) 143-147
33. Cancedda R., Descalzi C.F., and Castagnola P. Chondrocyte differentiation. Int Rev Cytol 159 (1995) 265-358
34. Wright E., Hargrave M.R., Christiansen J., Cooper L., Kun J., Evans T., et al. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat Genet 9 1 (1995) 15-20
35. Hering T.M. Regulation of chondrocyte gene expression. Front Biosci 4 (1999) D743-D761
36. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., and De Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17 4 (1997) 2336-2346
37. Zhao Q., Eberspaecher H., Lefebvre V., and De Crombrugghe B. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209 4 (1997) 377-386
38. Li Y., Tew S.R., Russell A.M., Gonzalez K.R., Hardingham T.E., and Hawkins R.E. Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. Tissue Eng 10 3-4 (2004) 575-584
39. Tew S.R., Li Y., Pothacharoen P., Tweats L.M., Hawkins R.E., and Hardingham T.E. Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage 13 1 (2005) 80-89
40. Bai X., Xiao Z., Pan Y., Hu J., Pohl J., Wen J., et al. Cartilage-derived morphogenetic protein-1 promotes the differentiation of mesenchymal stem cells into chondrocytes. Biochem Biophys Res Commun 325 2 (2004) 453-460
41. Cheng S.L., Yang J.W., Rifas L., Zhang S.F., and Avioli L.V. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134 1 (1994) 277-286
42. Martin I., Jakob M., Schafer D., Dick W., Spagnoli G., and Heberer M. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage 9 2 (2001) 112-118
43. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 4 (2001) 402-408
44. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 7 (2002) RESEARCH0034
45. Mikos A.G., Sarakinos G., Leite S.M., Vacanti J.P., and Langer R. Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials 14 5 (1993) 323-330
46. Mikos A.G., Thorsen A.J., Czerwonka L.A., Bao Y., Langer R., Winslow D.N., et al. Preparation and characterization of poly(l-lactic acid) foams. Polymer 35 5 (1994) 1068-1077
47. Kim B.S., and Mooney D.J. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol 16 5 (1998) 224-230
48. Peter S.J., Miller M.J., Yasko A.W., Yaszemski M.J., and Mikos A.G. Polymer concepts in tissue engineering. J Biomed Mater Res 43 4 (1998) 422-427
49. Mwale F., Roughley P., and Antoniou J. Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc. Eur Cell Mater 8 (2004) 58-63
50. Makower A.M., Wroblewski J., and Pawlowski A. Effects of IGF-I, EGF, and FGF on proteoglycans synthesized by fractionated chondrocytes of rat rib growth plate. Exp Cell Res 179 2 (1988) 498-506
51. Li J., Kim K.S., Park J.S., Elmer W.A., Hutton W.C., and Yoon S.T. BMP-2 and CDMP-2: stimulation of chondrocyte production of proteoglycan. J Orthop Sci 8 6 (2003) 829-835